申请人:Stadtmueller Heinz
公开号:US20110237598A1
公开(公告)日:2011-09-29
The present invention encompasses compounds of general formulae (1
a
) and (1
b
)
wherein
the groups R
1
to R
5
, A, Q, m, n, p and q are defined as in claim
1
, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use as medicaments.
本发明涵盖通式(1a)和(1b)的化合物,其中R1到R5,A,Q,m,n,p和q的定义如权利要求1所述,适用于治疗因细胞过度或异常增殖而特征化的疾病,并作为药物使用。